Companies Dominating the Human Microbiome Landscape
- Seres Therapeutics, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Evelo Biosciences, Inc.
- Synlogic, Inc.
- Second Genome Inc.
- Synthetic Biologics, Inc.
- YSOPIA Bioscience
- 4D Pharma plc
- DuPont de Nemours, Inc.
- BiomX Inc.
- Sun Genomics, Inc.
- Viome Life Sciences, Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Human Microbiome Market in 2025 is evaluated at USD 558.65 million.
The global market size was worth over USD 445.92 million in 2024 and is poised to grow at a CAGR of around 31.6%, reaching USD 15.83 billion revenue by 2037.
North America is anticipated to collect USD 5.54 billion by 2037, fueled by rising pet adoption and an increase in government initiatives to study microbial communities.
The major players in the market include Seres Therapeutics, Inc., Evelo Biosciences, Inc., Synlogic, Inc., Second Genome Inc., Synthetic Biologics, Inc., YSOPIA Bioscience, 4D Pharma plc, DuPont de Nemours, Inc., BiomX Inc., Sun Genomics, Inc., Viome Life Sciences, Inc.
